Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Dec;10(6):889–892. doi: 10.1128/aac.10.6.889

Antibiotic Synergy and Antagonism Against Clinical Isolates of Klebsiella Species

Robert M D'Alessandri 1, David J McNeely 1, Ronica M Kluge 1
PMCID: PMC429860  PMID: 1008547

Abstract

Minimal inhibitory concentrations of kanamycin, gentamicin, amikacin, cephalothin, and chloramphenicol were determined in Trypticase soy broth for 70 clinical isolates of Klebsiella species. Gentamicin and amikacin were the most active on a weight basis. Chloramphenicol was more active than kanamycin, and cephalothin was the least active of all. Studies using a microtiter modification of the checkerboard technique were performed to evaluate the comparative activity of the three aminoglycosides in combination with either chloramphenicol or cephalothin. The cephalothin-aminoglycoside combinations demonstrated synergy in >80% of the isolates tested. No antagonism was noted. The chloramphenicol-aminoglycoside combinations showed antagonism in 35 to 45% of the isolates tested. The data suggest that the chloramphenicol-aminoglycoside combinations be used with caution when treating serious infections where Klebsiella is a potential pathogen.

Full text

PDF
889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Stewart D. In vitro studies of BB-K8, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1973 Aug;4(2):186–192. doi: 10.1128/aac.4.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bulger R. J. In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics. Ann Intern Med. 1967 Sep;67(3):523–532. doi: 10.7326/0003-4819-67-3-523. [DOI] [PubMed] [Google Scholar]
  3. Klastersky J., Cappel R., Daneau D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother. 1972 Dec;2(6):470–475. doi: 10.1128/aac.2.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Klastersky J., Cappel R., Swings G., Vandenborre L. Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations. Am J Med Sci. 1971 Nov;262(5):283–290. doi: 10.1097/00000441-197111000-00006. [DOI] [PubMed] [Google Scholar]
  5. Kluge R. M., Standiford H. C., Tatem B., Young V. M., Greene W. H., Schimpff S. C., Calia F. M., Hornick R. B. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974 Oct;6(4):442–446. doi: 10.1128/aac.6.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Luboshitzky R., Sacks T., Michel J. Bactericidal effect of combinations of antibiotics on Klebsiella-Enterobacter-Serratia. Chemotherapy. 1973;19(6):354–366. doi: 10.1159/000221476. [DOI] [PubMed] [Google Scholar]
  7. Martin C. M., Cuomo A. J., Geraghty M. J., Zager J. R., Mandes T. C. Gram-negative rod bacteremia. J Infect Dis. 1969 Apr-May;119(4):506–517. doi: 10.1093/infdis/119.4-5.506. [DOI] [PubMed] [Google Scholar]
  8. Warren E., Snyder R. J., Washington JA I. I. Four-hour microbiological assay of gentamicin in serum. Antimicrob Agents Chemother. 1972 Jan;1(1):46–48. doi: 10.1128/aac.1.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Washington J. A., 2nd, Ritts R. E., Jr, Martin W. J. In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc. 1970 Feb;45(2):146–149. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES